Our Story

Advancing medical intelligence to the next level

Lunit is a medical AI software company devoted to conquering cancer and advancing medical intelligence to the next level. Lunit develops and provides novel AI-powered solutions for cancer diagnostics and therapeutics that can save time and save lives.

Our Journey

2013
- Lunit Inc. founded
2014
- Ranked 7th place in ImageNet <ILSVRC 2014>
2015
- Raised $2M (Seed)
- Ranked 5th place in ImageNet <ILSVRC 2015>
2016
- Raised $3.5M (Series A)
- 1st place in MICCAI Tumor Proliferation Assessment Challenge 2016
2017
- Top 100 AI startup, by CB Insights
- Top 5 “Social Impact” AI startup, by NVIDIA
- Ranked 1st place in <CAMELYON Grand Challenge 2017>
- 5th place in <The Digital Mammography DREAM Challenge 2017>
- Launched its first product, <Lunit INSIGHT CXR-Nodule>
2018
- Raised $15M (Series B)
- Ministry of Korea Food and Drug Safety clearance, <Lunit INSIGHT CXR-Nodule>
- Launched its second product, <Lunit INSIGHT MMG>
2019
- Digital Health 150, by CB Insights
- Ministry of Korea Food and Drug Safety clearance, <Lunit INSIGHT MMG>
- Europe CE marked, <Lunit INSIGHT CXR>
- 1st place in <Visual Domain Adaptation Challenge>
2020
- Raised $26M (Series C, Tranche A)
- Europe CE certified, <Lunit INSIGHT MMG>
- Awarded by World Economic Forum as one of 100 “Technology Pioneer 2020